Caribou Biosciences, Inc. (CRBU) Financials
CRBU Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 142.8 million | 44.7 million |
| March 31, 2026 | 149.0 million | 47.0 million |
| Dec. 31, 2025 | 179.6 million | 57.5 million |
| Sept. 30, 2025 | 195.0 million | 53.1 million |
CRBU Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -22.8 million | 2.5 million |
| March 31, 2026 | -27.1 million | 2.4 million |
| Dec. 31, 2025 | -20.6 million | 2.7 million |
| Sept. 30, 2025 | -25.3 million | 2.9 million |
CRBU Net Income
No data available :(
CRBU Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 112.3 million | - | - |
| March 31, 2026 | 117.6 million | - | 26.9 million |
| Dec. 31, 2025 | 139.3 million | - | 27.2 million |
| Sept. 30, 2025 | 147.3 million | - | 25.5 million |
CRBU Shares Outstanding
CRBU Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 1000 | 18.9 million | 7.9 million | - |
| March 31, 2026 | 72000 | 20.6 million | 8.1 million | - |
| Dec. 31, 2025 | 216000 | 23.8 million | 8.6 million | - |
| Sept. 30, 2025 | 115000 | 22.4 million | 9.2 million | - |
CRBU Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.5 million | - |
| March 31, 2026 | 2.4 million | 649000 |
| Dec. 31, 2025 | 3.9 million | 682000 |
| Sept. 30, 2025 | 2.2 million | 22.4 million |
CRBU Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CRBU
Price: $0.47
52 week price:
Earnings Per Share: -1.06 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 355500
Market Capitalization: 61.5 million